Francis X. Brennan, PhD

Articles by Francis X. Brennan, PhD

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

ByJesen Fagerness, JD,Eileen Fonseca, MS,Gregory P. Hess, MD, MBA, MSc,Rachel Scott, PharmD,Kathryn R. Gardner, MS,Michael Koffler, MBA,Maurizio Fava, MD,Roy H. Perlis, MD, MSc,Francis X. Brennan, PhD,Jay Lombard, DO

May 20th 2014

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.

Latest Updated Articles

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings
May 20th 2014

Francis X. Brennan, PhD

Articles by Francis X. Brennan, PhD

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Latest Updated Articles

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship